GlassScriptPhysician profile
Michael J Flanagan
NPI 1902860166
$5,897.20
in general payments reported to CMS, 2019-2025
40 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,265 · 2020: $509 · 2021: $892 · 2022: $708 · 2023: $1,077 · 2024: $1,092 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,375 · Education: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,374.50 |
| Education | $147.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $832.80 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $500.68 | 2019-2024 | Erleada, Akeega |
| C. R. Bard, INC. & Subsidiaries | $425.40 | 2020-2024 | Bard Urinary Drainage Bag |
| Pfizer INC. | $405.90 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $398.54 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $334.18 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $260.67 | 2019-2022 | |
| Progenics Pharmaceuticals, INC. | $241.86 | 2022-2023 | Pylarify |
| Amgen INC. | $226.93 | 2019-2022 | |
| Abbvie INC. | $213.64 | 2019-2025 | |
| Acerus Pharmaceuticals Corporation | $194.60 | 2020-2022 | |
| Bard Access Systems, INC. | $144.85 | 2019 | |
| Boston Scientific Corporation | $138.21 | 2019-2021 | |
| Tolmar, INC. | $125.79 | 2023-2025 | Jatenzo |
| Novartis Pharmaceuticals Corporation | $109.13 | 2023-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $99.99 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $97.03 | 2021-2022 | |
| Aytu Biopharma, INC. | $94.75 | 2019-2020 | |
| Urogen Pharma, INC. | $93.83 | 2023-2025 | Jelmyto |
| Myovant Sciences INC. | $85.01 | 2021-2022 | |
| Teleflex LLC | $83.13 | 2022-2025 | Urolift, Barrigel |
| Inspire Medical Systems, INC. | $78.94 | 2025 | Inspire |
| Endo Pharmaceuticals INC. | $73.26 | 2019-2023 | Xiaflex, Edex, Aveed |
| Dentsply Ih INC. | $68.01 | 2020-2021 | |
| Coloplast Corp | $61.17 | 2021 | |
| Urovant Sciences INC | $59.62 | 2022 | |
| Myriad Genetic Laboratories, INC. | $52.74 | 2021-2024 | Myrisk |
| Ferring Pharmaceuticals INC. | $47.84 | 2019-2024 | Adstiladrin |
| Antares Pharma, INC. | $47.62 | 2020-2024 | Xyosted |
| 180 Medical, INC. | $43.21 | 2019-2024 | |
| Shockwave Medical, INC | $41.04 | 2022 | |
| Accord Healthcare, INC. | $39.78 | 2022-2023 | |
| Allergan, INC. | $35.15 | 2019 | |
| Telix Pharmaceuticals | $26.41 | 2023 | Illuccix |
| Palette Life Sciences, INC. | $25.73 | 2022 | |
| Medtronic, INC. | $23.59 | 2024 | Interstim |
| Genzyme Corporation | $21.31 | 2021 | |
| Mission Pharmacal Company | $18.16 | 2023 | Uribel |
| Travere Therapeutics, INC. | $13.96 | 2019 | |
| Avanos Medical | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Flanagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.